Management of postoperative bleeding in surgically debrided wounds: topical hemostat versus electrocautery

We are please to announce that new evidence supporting the use of our hemostatic granules in wound debridement has been published by the Journal of Wound Care. Journal articles are rigorously peer-reviewed by an international panel of experts and we are thrilled this article was accepted for publication. The publication was lead by wound care experts from The Wound Treatment Center, LLC at Opelousas General Health in Lafayette, LA which demonstrates the effectiveness of OMNI-STAT in achieving hemostasis while also saving time and thus offers potential for increased cost-effectiveness, relative to electrocautery. You can find the full publication in the Journal of Wound Care here.

Citation details and abstract below.

Use this link to request a clinical re-print.

For additional information about our products or to chat to one of our expert representative please contact us.

Management of postoperative bleeding in surgically debrided wounds: topical hemostat versus electrocautery

Kerry T Thibodeaux, Marcus S Speyrer, Ryan P Thibodeaux, Alan A Rogers and Mark G Rippon

Journal of Wound Care VOL. 29,NO.8 444-451 – Published on line August 17^th 2020

Abstract

Objective:

To compare the effectiveness of a temporary topical external hemostat (OMNI-STAT Granules, Omni-stat Medical Inc., US) versus the use of electrocautery for bleeding control in patients who have undergone surgical wound debridement. Time saved in the operating room (OR) was evaluated.

Method:

A prospective evaluation of use of a topical hemostat in an OR setting was compared with retrospective data collected using electrocautery to understand the time-saving benefits of using a topical hemostat versus electrocautery.

Results:

A total of 52 patients were treated with the topical hemostat, and 89 patients with electrocautery. The topical hemostat was shown to be as effective in achieving hemostasis post-surgical debridement as electrocautery, with the added benefits of significant time savings in the OR (reducing the mean total OR time by 19.1%). Additionally, preprocedure and surgical procedure times in patients treated with the topical hemostat were significantly reduced. The results showed that wounds treated with the topical hemostat demonstrated a more advanced stage of healing, which may be a result of the lack of tissue damage demonstrated with the topical hemostat compared with electrocautery.

Conclusion:

This study found that the temporary topical hemostat was equally as effective as cauterisation in achieving hemostasis. In addition, significant saving in OR time was demonstrated relative to electrocautery. The improved OR times may translate into increased cost-effectiveness, relative to electrocautery, by increasing the number of surgical cases per day and/or using resources more effectively to treat more patients. It may also enable bleeding control in the outpatient clinic or at the bedside, freeing up costly OR time and enabling more effective management of healthcare resources.

Find out more about OMNI-STAT® Topical Hemostats

Explore our website for additional evidence of use of Omni-stat or to find out more about our hemostatic granules. Don’t hesitate to reach out to request a product demonstration, in-service or to meet with a sales representative.